Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [21] Rituximab bioavailability in primary membranous nephropathy
    Boyer-Suavet, Sonia
    Andreani, Marine
    Cremoni, Marion
    Brglez, Vesna
    Benzaken, Sylvia
    Bernard, Ghislaine
    Nachman, Patrick
    Esnault, Vincent
    Seitz-Polski, Barbara
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (08) : 1423 - 1425
  • [22] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I2090 - I2091
  • [23] Efficacy of continues low dose rituximab in PLA2R-associated primary membranous nephropathy
    Cui, Zhuan
    Wang, Song
    Wanf, Yue
    Zheng, Danxia
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [24] Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy
    Teisseyre, Maxime
    Cremoni, Marion
    Boyer-Suavet, Sonia
    Ruetsch, Caroline
    Graca, Daisy
    Esnault, Vincent L. M.
    Brglez, Vesna
    Seitz-Polski, Barbara
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
    Yao-Wei Wang
    Xin-Hui Wang
    Hong-Xia Wang
    Ren-Huan Yu
    World Journal of Clinical Cases, 2023, (03) : 566 - 575
  • [26] Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy
    Wan, Qi-Jun
    Hu, Hao-Fei
    He, Yong-Cheng
    Luan, Shao-Dong
    Chen, Hong-Tao
    Li, Tong
    Xu, Yi
    Xu, Hui-Li
    Liao, Ying
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 12 (03) : 1934 - 1938
  • [27] Successful treatment of patients with refractory idiopathic membranous nephropathy with low-dose Rituximab: A single-center experience
    Wang, Yao-Wei
    Wang, Xin-Hui
    Wang, Hong-Xia
    Yu, Ren-Huan
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (03) : 566 - 575
  • [28] Rituximab in Primary Membranous Nephropathy With Severe CKD
    Naik, Sachin
    Shukla, Shubham
    Kumar, Vinod
    Sain, Thakur
    Sekar, Aravind
    Pal, Deeksha
    Kumar, Ashwini
    Minz, Ranjana
    Rathi, Manish
    Nada, Ritambhra
    Kohli, Harbir Singh
    Ramachandran, Raja
    KIDNEY INTERNATIONAL REPORTS, 2023, 8 (06): : 1270 - 1271
  • [29] EFFICACY OF RITUXIMAB IN A CASE OF PRIMARY MEMBRANOUS NEPHROPATHY
    Printza, Nikoleta
    Stabouli, Stella
    Dotis, John
    Georeli, Ireni
    Maliahova, Olga
    Sidira, Christina
    Papachristou, Fotios
    PEDIATRIC NEPHROLOGY, 2017, 32 (09) : 1777 - 1777
  • [30] LOW-DOSE CYCLOSPORINE MONOTHERAPY V COMBINATION THERAPIES
    SALAMAN, JR
    TRANSPLANTATION AND CLINICAL IMMUNOLOGY, VOL XX: COMBINED IMMUNOSUPPRESSIVE THERAPY IN TRANSPLANTATION, 1989, 14 : 73 - 84
12345